(Q34519411)

2 August 2017

1 reference

title

Mechanisms of inverse agonism at G-protein-coupled receptors (English)

1 reference

G protein-coupled receptor

2 August 2017

main subject

0 references

author name string

Philip G Strange

series ordinal

1 reference

2 August 2017

publication date

1 February 2002

1 reference

Trends in Pharmacological Sciences

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

89-95

1 reference

An allosteric model for benzodiazepine receptor function

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Inverse, protean, and ligand-selective agonism: matters of receptor conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Inverse agonism and the regulation of receptor number

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Agonist-independent regulation of constitutively active G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Agonist-independent activation of Gz by the 5-hydroxytryptamine1A receptor co-expressed in Spodoptera frugiperda cells. Distinguishing inverse agonists from neutral antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

High constitutive activity of native H3 receptors regulates histamine neurons in brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Constitutive activity and structural instability of the wild-type human H2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Nicotinic receptors at the amino acid level

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

The two-state model of receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Inverse agonist activity at the alpha(2A)-adrenergic receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Mechanisms of agonism and inverse agonism at serotonin 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Two populations of binding sites for muscarinic antagonists in the rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Interactions of purified bovine brain A1-adenosine receptors with G-proteins. Reciprocal modulation of agonist and antagonist binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Characterization of recombinant human serotonin 5HT1A receptors expressed in Chinese hamster ovary cells. [3H]spiperone discriminates between the G-protein-coupled and -uncoupled forms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Site-directed mutations in the third intracellular loop of the serotonin 5-HT(1A) receptor alter G protein coupling from G(i) to G(s) in a ligand-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Effects of GTP on 3H-domperidone binding and its displacement by dopamine in rat striatal homogenates

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Heterogeneity of D2 dopamine receptors in different brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

G protein-coupled receptors. II. Mechanism of agonist activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Porcine m2 muscarinic acetylcholine receptor-effector coupling in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2901993-4

7 January 2021

10.1016/S0165-6147(02)01993-4

Identifiers

DOI

1 reference

2 August 2017

1 reference